HomeALA • ASX
add
Arovella Therapeutics Ltd
Previous close
$0.093
Day range
$0.092 - $0.11
Year range
$0.091 - $0.21
Market cap
106.07M AUD
Avg Volume
1.81M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.72M | 76.95% |
Operating expense | 2.57M | -13.76% |
Net income | -730.79K | 62.96% |
Net profit margin | -42.50 | 79.07% |
Earnings per share | — | — |
EBITDA | -828.87K | 58.56% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.75M | 146.70% |
Total assets | 12.65M | 137.38% |
Total liabilities | 1.11M | -49.55% |
Total equity | 11.54M | — |
Shares outstanding | 1.06B | — |
Price to book | 9.30 | — |
Return on assets | -16.87% | — |
Return on capital | -18.49% | — |
Cash Flow
Net change in cash
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -730.79K | 62.96% |
Cash from operations | -906.96K | 31.28% |
Cash from investing | -179.56K | -324.24% |
Cash from financing | 603.79K | -47.26% |
Net change in cash | -481.56K | -133.82% |
Free cash flow | -433.08K | 56.54% |
About
Founded
1999
Website
Employees
14
